黑料吃瓜资源 (CSHL) Professor Adrian Krainer has been included in .
The magazine recognized Krainer for research that 鈥渓ed to the development of Spinraza, the first FDA-approved medicine for spinal muscular atrophy,鈥� and for co-founding biotech company .
After growing up in Uruguay, Krainer came to the U.S. in 1977 to study biochemistry at Columbia University. In 1986, he received his Ph.D. from Harvard University and became the first participant in CSHL鈥檚 prestigious Fellows Program. (Hear more about Krainer鈥檚 early days in our 鈥淪ink or Swim鈥� podcast.)
Forty years later, Krainer is CSHL鈥檚 St. Giles Foundation Professor and a recipient of some of biomedical science鈥檚 highest awards, including the Breakthrough and Albany prizes. With this latest accolade, Krainer joins a list of 250 immigrants, topped by Arnold Schwarzenegger and Elon Musk, which also includes Nobel Prize winners Katalin Karik贸 and , among other luminaries.
鈥淎drian is a remarkable scientist who immigrated to the United States and has committed his career to helping solve some of medicine鈥檚 toughest challenges,鈥� said CSHL President & CEO Bruce Stillman. 鈥淗is work on RNA splicing and the subsequent development of new therapeutics have impacted families and saved lives. He chose to do that work here in the U.S., which is an example of the incredible strength immigrants bring to the U.S. scientific endeavor.鈥�
Written by: Samuel Diamond, Senior Communications Strategist | [email protected] | 516-367-5055